Lack of birth defects following in utero paroxetine exposure

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2006年 / 1108卷 / 1期

关键词：

Pregnant Woman; Congenital Abnormality; Paroxetine; Pregnancy Outcome; Medium Release;

D O I：

10.2165/00128415-200611080-00005

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：3 / 3

相关论文

共 50 条

[21] Glucose/propranolol/thiamazoleHypoglycaemia following in-utero exposure and lack of efficacy
Reactions Weekly, 2024, 2001 (1) : 154 - 154
[22] AntineoplasticsOligoamnios, in utero growth restriction and low birth weight following in utero exposure: case report
Reactions Weekly, 2018, 1711 (1) : 31 - 31
[23] Amiodarone/metoprololLow birth weight following in utero exposure: case report
Reactions Weekly, 2018, 1683 (1) : 49 - 49
[24] Methylprednisolone/prednisoloneLow birth weight following in utero exposure: case report
Reactions Weekly, 2017, 1633 (1) : 495 - 495
[25] Birth outcomes following in utero co-exposure to tobacco and marijuana
Waddell, Madison L.
Dickson, Samantha A.
Dodge, Phoebe A.
Kopkau, Haley E.
Nadolski, Katherine N.
Zablocki, Victoria
Forrestal, Kaya M.
Bailey, Beth A.
BIRTH DEFECTS RESEARCH, 2024, 116 (01):
[26] EfavirenzLow birth weight following in-utero exposure: case report
Reactions Weekly, 2019, 1764 (1) : 121 - 121
[27] AntiretroviralsNeural tube defects following in utero exposure: 3 case reports
Reactions Weekly, 2019, 1774 (1) : 54 - 54
[28] OfloxacinBirth defects following in-utero exposure: 2 case reports
Reactions Weekly, 2018, 1719 (1) : 173 - 173
[29] MethotrexateEmbryopathy and heart defects following in-utero exposure: case report
Reactions Weekly, 2019, 1748 (1) : 326 - 326
[30] PAROXETINE AND CARDIAC BIRTH DEFECTS: A CAUSAL ROLE
Hinds, D.
Chang, A.
Kramer, S.
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2011, 173 : S213 - S213

← 1 2 3 4 5 →